Abstract:Molecular recognition is fundamental in biology, underpinning intricate processes through specific protein–ligand interactions. This understanding is pivotal in drug discovery, yet traditional experimental methods face limitations in exploring the vast chemical space. Computational approaches, notably quantitative structure–activity/property relationship analysis, have gained prominence. Molecular fingerprints encode molecular structures and serve as property profiles, which are essential in drug discovery. While two-dimensional (2D) fingerprints are commonly used, three-dimensional (3D) structural interaction fingerprints offer enhanced structural features specific to target proteins. Machine learning models trained on interaction fingerprints enable precise binding prediction. Recent focus has shifted to structure-based predictive modeling, with machine-learning scoring functions excelling due to feature engineering guided by key interactions. Notably, 3D interaction fingerprints are gaining ground due to their robustness. Various structural interaction fingerprints have been developed and used in drug discovery, each with unique capabilities. This review recapitulates the developed structural interaction fingerprints and provides two case studies to illustrate the power of interaction fingerprint-driven machine learning. The first elucidates structure–activity relationships in β2 adrenoceptor ligands, demonstrating the ability to differentiate agonists and antagonists. The second employs a retrosynthesis-based pre-trained molecular representation to predict protein–ligand dissociation rates, offering insights into binding kinetics. Despite remarkable progress, challenges persist in interpreting complex machine learning models built on 3D fingerprints, emphasizing the need for strategies to make predictions interpretable. Binding site plasticity and induced fit effects pose additional complexities. Interaction fingerprints are promising but require continued research to harness their full potential.

Seq3seq Fingerprint

Seq2seq Fingerprint: An Unsupervised Deep Molecular Embedding for Drug Discovery

TF3P: Three-dimensional Force Fields Fingerprint Learned by Deep Capsular Network

DeepGS: Deep Representation Learning of Graphs and Sequences for Drug-Target Binding Affinity Prediction

FingerDTA: A Fingerprint-Embedding Framework for Drug-Target Binding Affinity Prediction

Drug-Target Indication Prediction by Integrating End-to-End Learning and Fingerprints

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

Extracting Predictive Representations from Hundreds of Millions of Molecules

Fingerprinting Interactions between Proteins and Ligands for Facilitating Machine Learning in Drug Discovery

Permutationally Invariant Deep Learning Approach to Molecular Fingerprinting with Application to Compound Mixtures

Deep Learning Methods for Small Molecule Drug Discovery: A Survey

A deep learning framework for automated molecular recognitions in scanning probe microscopy images.

A Novel Drug–Target Interaction Prediction Model Using Neural Fingerprint and Self-Attention Mechanism

A deep-learning system bridging molecule structure and biomedical text with comprehension comparable to human professionals

Predicting adverse drug reactions through interpretable deep learning framework

Breaking the barriers of data scarcity in drug–target affinity prediction

Application advances of deep learning methods for de novo drug design and molecular dynamics simulation

An effective self-supervised framework for learning expressive molecular global representations to drug discovery

MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction

Virtual Screening of Molecules via Neural Fingerprint-based Deep Learning Technique

SubMDTA: drug target affinity prediction based on substructure extraction and multi-scale features